TLX

Telix Pharmaceuticals Limited

Healthcare›Biotechnology|NASDAQ Global Select|AU

Price

$9.13

Market Cap

$3.09B

Beta

0.61

P/E

86.3

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+201.33%

EPS Growth (YoY)+135.45%

Revenue CAGR 3Y+500.00%

P/E Ratio86.3

PEG Ratio0.60

FCF Yield-1.65%

Debt / Equity1.26

Interest Coverage2.9x

No credit card required

Already have an account? Sign in to view the full analysis for TLX.